InspireMD, Inc. Net Income Loss

• InspireMD, Inc. showed a decrease of -52.4% in Net Income Loss from 2024 to 2025.
• This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), InspireMD, Inc.'s Net Income Loss has declined by 1,691.0%.
• Historical annual values: Fiscal year 2025: -$48.79 million | Fiscal year 2024: -$32.01 million | Fiscal year 2023: -$19.92 million | Fiscal year 2022: -$18.49 million | Fiscal year 2021: -$14.92 million | Fiscal year 2020: -$10.54 million | Fiscal year 2019: -$10.04 million | Fiscal year 2018: -$7.24 million | Fiscal year 2017: -$8.44 million | Fiscal year 2016: -$8.46 million | Fiscal year 2015: -$15.59 million | Fiscal year 2014: -$25.10 million | Fiscal year 2013: -$29.26 million | Fiscal year 2012: -$17.60 million | Fiscal year 2011: -$14.67 million | Fiscal year 2010: -$3.42 million | Fiscal year 2009: -$2.72 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026